Jon MD - Opko Health Advisor
| OPK Stock | 596.00 40.40 7.27% |
Insider
Jon MD is Advisor of Opko Health
| Age | 68 |
| Phone | 305 575 4100 |
| Web | https://www.opko.com |
Opko Health Management Efficiency
The company has return on total asset (ROA) of (0.0659) % which means that it has lost $0.0659 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1867) %, meaning that it generated substantial loss on money invested by shareholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Hanni Neheman | Kamada | 53 | |
| Deborah Griffin | Teva Pharmaceutical Industries | N/A | |
| Abbas Hussain | Teva Pharmaceutical Industries | 54 | |
| Haim Delmar | Elbit Systems | 49 | |
| Ariella Raban | Kamada | 47 | |
| Janet Vergis | Teva Pharmaceutical Industries | 54 | |
| Eli Shani | Teva Pharmaceutical Industries | N/A | |
| Rami Myerson | Elbit Systems | N/A | |
| Ari Shamiss | Kamada | N/A | |
| Bilha Shapira | Elbit Systems | 66 | |
| Jerry Neal | Tower Semiconductor | 74 | |
| Kare Schultz | Teva Pharmaceutical Industries | 62 | |
| Dani Ashkenazi | Tower Semiconductor | 60 | |
| Noit LevyKaroubi | Tower Semiconductor | 38 | |
| Andrew Weil | Teva Pharmaceutical Industries | 52 | |
| Lilach Topilsky | Kamada | N/A | |
| Iris Avner | Tower Semiconductor | 54 | |
| Yifat Esq | Kamada | 46 | |
| Jon Knight | Kamada | N/A | |
| Shiri Neder | Nice | 47 | |
| Eran Nir | Kamada | 50 | |
Management Performance
| Return On Equity | -0.19 | |||
| Return On Asset | -0.0659 |
Opko Health Leadership Team
Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arie Gutman, Pres API | ||
| James DeMarco, VP Sales | ||
| Adam Logal, CFO, Chief Accounting Officer, Sr. VP and Treasurer | ||
| Phillip Frost, Chairman of the Board, CEO | ||
| Akhtar Ashfaq, Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division | ||
| Elias MD, Pres Chairman | ||
| JD Esq, Chief Laboratories | ||
| MBA MBA, Vice Officer | ||
| Jon MD, Advisor |
Opko Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Opko Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.19 | |||
| Return On Asset | -0.0659 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.9 B | |||
| Shares Outstanding | 772.69 M | |||
| Shares Owned By Insiders | 45.87 % | |||
| Shares Owned By Institutions | 24.36 % | |||
| Price To Book | 0.63 X | |||
| Price To Sales | 2.78 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Opko Stock
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Opko Stock refer to our How to Trade Opko Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.